The Los Angeles County Board of Supervisors on Tuesday passed a motion, sponsored by Board Chair Supervisor Hilda L. Solis, declaring April 5 through 9 “National Community Development Week.”
National Community Development Week is the county’s opportunity to commemorate the longstanding accomplishments of the federally funded Community Development Block Grant and HOME Investment Partnerships Programs.
This year marks the 35th year of this national effort to actively promote awareness, education, and advocacy for these much-needed programs.
The county is taking this opportunity to celebrate National Community Development Week and to commemorate the continued successes of the CDBG and HOME programs. These programs significantly impact Los Angeles County residents, especially during crises, such as the recent COVID-19 pandemic.
[co-author: David Wilson, Sr. Account Executive, Reed Tech]
On December 29, 2020, the U.S. Food and Drug Administration published a Federal Register notice setting the fee rates under the Over-the-Counter Monograph User Fee Act (OMUFA) Program for Fiscal Year 2021. Reed Tech contributors Carolina Wirth and Genevieve Razick, both of Arnall Golden Gregory, LLP, quickly digested the information and summarized the OMUFA program. More importantly, the authors provided some information regarding the types of facilities that were impacted by these fees. You can read the full bulletin here.
1 However, less than a week later, the Department of Health and Human Services (HHS) published a withdrawal of the notice creating a lot of uncertainty within the industry. According to the withdrawal notice, “FDA lacked the delegated authority” to issue the
On December 29, 2020, the U.S. Food and Drug Administration published a Federal Register notice setting the fee rates under the Over-the-Counter Monograph User Fee Act (OMUFA) Program for Fiscal Year 2021. Reed Tech contributors Carolina Wirth and Genevieve Razick, both of Arnall Golden Gregory, LLP, quickly digested the information and summarized the OMUFA program. More importantly, the authors provided some information regarding the types of facilities that were impacted by these fees. You can read the full bulletin here. However, less than a week later, the Department of Health and Human Services (HHS) published a withdrawal of the notice creating a lot of uncertainty within the industry. According to the withdrawal notice, “FDA lacked the delegated authority” to issue the